Beximco Pharmaceuticals PLC. (AIM:BXP)
London · Delayed Price · Currency is GBP · Price in GBX 42.00
0.00 (0.00%)
At close: Dec 5, 2025
AIM:BXP Market Cap
AIM:BXP has a market cap or net worth of 301.45 million as of December 5, 2025. Its market cap has increased by 41.51% in one year.
Market Cap
301.45M
Enterprise Value
346.13M
Revenue
309.11M
Ranking
n/a
PE Ratio
7.11
Stock Price
42.00
Market Cap Chart
Since January 3, 2000, AIM:BXP's market cap has increased from 22.96M to 301.45M, an increase of 1,212.82%. That is a compound annual growth rate of 10.44%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 4, 2025 | 301.45M | 24.35% |
| Dec 30, 2024 | 242.42M | -48.09% |
| Dec 28, 2023 | 466.99M | -11.21% |
| Dec 29, 2022 | 525.95M | -29.56% |
| Dec 30, 2021 | 746.62M | 1.29% |
| Dec 30, 2020 | 737.12M | 192.11% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 27, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 210.77B |
| GSK plc | 72.45B |
| Haleon | 32.02B |
| Smith & Nephew | 10.44B |
| Convatec Group | 4.49B |
| Hikma Pharmaceuticals | 3.53B |
| HUTCHMED (China) | 1.84B |
| Genus | 1.77B |